| NOTCH1 altered in cohorts of …ALTERED_INderived20 of 20show fewer |
|---|
| → altered in cohorts of | Skin Squamous Cell Carcinoma 46 / 83 cases (55 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 93 / 293 cases (32 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Carcinoma, Other 28 / 108 cases (26 %) · ssm · ohnca_cptac_gdc | — | — | Head and Neck Carcinoma, Other | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Adenoid Cystic Carcinoma 232 / 1,049 cases (22 %) · ssm · acc_2019 | — | — | Adenoid Cystic Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 39 / 181 cases (22 %) · ssm · ucec_ccr_msk_2022 · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | B Lymphoblastic Leukemia/Lymphoma 159 / 739 cases (22 %) · ssm · bll_target_gdc | — | — | B Lymphoblastic Leukemia/Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Acute Lymphoblastic Leukemia 163 / 768 cases (21 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinomasubtype 88 / 515 cases (17 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 32 / 247 cases (13 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 · largest of 2 cohorts | — | — | Bladder Urothelial Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 63 / 696 cases (9.1 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinomasubtype 35 / 447 cases (7.8 %) · ssm · nsclc_tracerx_2017 | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 40 / 518 cases (7.7 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 73 / 1,004 cases (7.3 %) · ssm · glioma_mskcc_2019 · largest of 6 cohorts | — | — | Diffuse Glioma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 20 / 291 cases (6.9 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 35 / 527 cases (6.6 %) · ssm · brca_msk_2025 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 459 / 7,237 cases (6.3 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 70 / 1,134 cases (6.2 %) · ssm · crc_msk_2017 · largest of 2 cohorts | — | — | Colorectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 38 / 755 cases (5.0 %) · ssm · mbn_mdacc_2013 | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Small Lymphocytic Lymphoma 54 / 1,075 cases (5.0 %) · ssm · cll_broad_2022 · largest of 3 cohorts | — | — | Small Lymphocytic Lymphoma | 3 | Observed | cbioportal | graph → |